Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2024

04-05-2024 | Hepatic Encephalopathy | Profiles and Perspectives

Increasing Healthcare System Empathy for Patients with Advanced Liver Disease: My Top 10 Lessons in Palliative Hepatology

Author: Nneka N. Ufere

Published in: Digestive Diseases and Sciences | Issue 6/2024

Login to get access

Excerpt

I am a transplant hepatologist who has a specific clinical and research focus on palliative hepatology. I have defined palliative hepatology as follows: Holistic care given to patients with advanced liver disease and their families to improve their quality of life over the entirety of their illness trajectory, both to and through transplantation and at the end of life.
Literature
1.
go back to reference Schomerus G, Leonhard A, Manthey J et al. The stigma of alcohol-related liver disease and its impact on healthcare. J Hepatol 2022;77:516–524.CrossRefPubMed Schomerus G, Leonhard A, Manthey J et al. The stigma of alcohol-related liver disease and its impact on healthcare. J Hepatol 2022;77:516–524.CrossRefPubMed
2.
go back to reference American Association for the Study of Liver Diseases, European Association for the Study of the Liver, Latin American Association for the Study of the Liver et al. Ending stigmatizing language in alcohol and liver disease: A liver societies’ statement. Hepatology 2023;78:1682–1683. American Association for the Study of Liver Diseases, European Association for the Study of the Liver, Latin American Association for the Study of the Liver et al. Ending stigmatizing language in alcohol and liver disease: A liver societies’ statement. Hepatology 2023;78:1682–1683.
3.
go back to reference Centers for Disease Control and Prevention National Center for Injury Prevention and Control. Web-Based Injury Statistics Query and Reporting System (WISQARS), Vol 2021. CDC: Atlanta, 2017. Centers for Disease Control and Prevention National Center for Injury Prevention and Control. Web-Based Injury Statistics Query and Reporting System (WISQARS), Vol 2021. CDC: Atlanta, 2017.
4.
go back to reference Ufere NN, Donlan J, Indriolo T et al. Burdensome transitions of care for patients with end-stage liver disease and their caregivers. Dig Dis Sci 2021;66:2942–2955.CrossRefPubMed Ufere NN, Donlan J, Indriolo T et al. Burdensome transitions of care for patients with end-stage liver disease and their caregivers. Dig Dis Sci 2021;66:2942–2955.CrossRefPubMed
5.
go back to reference Kaplan A, Comisar L, Ufere NN et al. Understanding prognosis: Discrepancy in prognosis estimates between patients with cirrhosis and their hepatologists. Clin Gastroenterol Hepatol 2023;21:1005–1012.CrossRefPubMed Kaplan A, Comisar L, Ufere NN et al. Understanding prognosis: Discrepancy in prognosis estimates between patients with cirrhosis and their hepatologists. Clin Gastroenterol Hepatol 2023;21:1005–1012.CrossRefPubMed
6.
go back to reference Gustot T, Stadlbauer V, Laleman W et al. Transition to decompensation and acute-on-chronic liver failure: role of predisposing factors and precipitating events. J Hepatol 2021;75(Suppl 1):S36–S48.CrossRefPubMed Gustot T, Stadlbauer V, Laleman W et al. Transition to decompensation and acute-on-chronic liver failure: role of predisposing factors and precipitating events. J Hepatol 2021;75(Suppl 1):S36–S48.CrossRefPubMed
7.
go back to reference Peng JK, Hepgul N, Higginson IJ et al. Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis. Palliat Med 2019;33:24–36.CrossRefPubMed Peng JK, Hepgul N, Higginson IJ et al. Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis. Palliat Med 2019;33:24–36.CrossRefPubMed
9.
go back to reference Patel AA, Tapper EB, Kanwal F et al. Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensus. Hepatol Commun 2023;7:e0135.CrossRefPubMedPubMedCentral Patel AA, Tapper EB, Kanwal F et al. Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensus. Hepatol Commun 2023;7:e0135.CrossRefPubMedPubMedCentral
10.
go back to reference Lago-Hernandez C, Nguyen NH, Khera R et al. Cost-related nonadherence to medications among US adults with chronic liver diseases. Mayo Clin Proc 2021;96:2639–2650.CrossRefPubMed Lago-Hernandez C, Nguyen NH, Khera R et al. Cost-related nonadherence to medications among US adults with chronic liver diseases. Mayo Clin Proc 2021;96:2639–2650.CrossRefPubMed
11.
go back to reference Bajaj JS, Wade JB, Gibson DP et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol 2011;106:1646–1653.CrossRefPubMedPubMedCentral Bajaj JS, Wade JB, Gibson DP et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol 2011;106:1646–1653.CrossRefPubMedPubMedCentral
12.
13.
go back to reference Philip G, Hookey L, Richardson H et al. Alcohol-associated liver disease is now the most common indication for liver transplant waitlisting among young American adults. Transplantation 2022;106:2000–2005.CrossRefPubMed Philip G, Hookey L, Richardson H et al. Alcohol-associated liver disease is now the most common indication for liver transplant waitlisting among young American adults. Transplantation 2022;106:2000–2005.CrossRefPubMed
15.
16.
go back to reference Kwong AJ, Devuni D, Wang C et al. Outcomes of liver transplantation among older recipients with nonalcoholic steatohepatitis in a large multicenter US Cohort: The re-evaluating age limits in transplantation consortium. Liver Transpl 2020;26:1492–1503.CrossRefPubMedPubMedCentral Kwong AJ, Devuni D, Wang C et al. Outcomes of liver transplantation among older recipients with nonalcoholic steatohepatitis in a large multicenter US Cohort: The re-evaluating age limits in transplantation consortium. Liver Transpl 2020;26:1492–1503.CrossRefPubMedPubMedCentral
17.
go back to reference Kochar B, Ufere NN, Ritchie CS et al. The 5Ms of geriatrics in gastroenterology: The path to creating age-friendly care for older adults with inflammatory bowel diseases and cirrhosis. Clin Transl Gastroenterol 2022;13:e00445.CrossRefPubMedPubMedCentral Kochar B, Ufere NN, Ritchie CS et al. The 5Ms of geriatrics in gastroenterology: The path to creating age-friendly care for older adults with inflammatory bowel diseases and cirrhosis. Clin Transl Gastroenterol 2022;13:e00445.CrossRefPubMedPubMedCentral
18.
go back to reference Su F, Yu L, Berry K et al. Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit. Gastroenterology 2016;150:441–453.CrossRefPubMed Su F, Yu L, Berry K et al. Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit. Gastroenterology 2016;150:441–453.CrossRefPubMed
19.
go back to reference Ufere NN, El-Jawahri A, Ritchie C et al. Promoting prognostic understanding and health equity for patients with advanced liver disease: Using “best case/worst case.” Gastroenterology 2023;164:171–176.CrossRefPubMed Ufere NN, El-Jawahri A, Ritchie C et al. Promoting prognostic understanding and health equity for patients with advanced liver disease: Using “best case/worst case.” Gastroenterology 2023;164:171–176.CrossRefPubMed
20.
go back to reference Saly DL, Allegretti AS, Ufere NN, et al. The SILK Collaborative: A multidisciplinary approach to serious illness communication for patients with liver failure and acute kidney injury. Kidney360 2024 Feb 7. Online ahead of print. Saly DL, Allegretti AS, Ufere NN, et al. The SILK Collaborative: A multidisciplinary approach to serious illness communication for patients with liver failure and acute kidney injury. Kidney360 2024 Feb 7. Online ahead of print.
21.
go back to reference Kaplan A, Fortune B, Ufere N et al. National trends in location of death in patients with end-stage liver disease. Liver Transpl 2021;27:165–176.CrossRefPubMed Kaplan A, Fortune B, Ufere N et al. National trends in location of death in patients with end-stage liver disease. Liver Transpl 2021;27:165–176.CrossRefPubMed
22.
go back to reference Macken L, Bremner S, Gage H et al. Randomised clinical trial: Palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis. Aliment Pharmacol Ther 2020;52:107–122.CrossRefPubMed Macken L, Bremner S, Gage H et al. Randomised clinical trial: Palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis. Aliment Pharmacol Ther 2020;52:107–122.CrossRefPubMed
23.
go back to reference Tandon P, Walling A, Patton H et al. AGA Clinical Practice Update on palliative care management in cirrhosis: Expert review. Clin Gastroenterol Hepatol 2021;19:646–656.CrossRefPubMed Tandon P, Walling A, Patton H et al. AGA Clinical Practice Update on palliative care management in cirrhosis: Expert review. Clin Gastroenterol Hepatol 2021;19:646–656.CrossRefPubMed
24.
go back to reference Rogal S, Hansen L, Patel A et al. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology 2022;76:819–853.CrossRefPubMed Rogal S, Hansen L, Patel A et al. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology 2022;76:819–853.CrossRefPubMed
25.
go back to reference Verma S, Hingwala J, Low JTS et al. Palliative clinical trials in advanced chronic liver disease: Challenges and opportunities. J Hepatol 2023;79:1236–1253.CrossRefPubMed Verma S, Hingwala J, Low JTS et al. Palliative clinical trials in advanced chronic liver disease: Challenges and opportunities. J Hepatol 2023;79:1236–1253.CrossRefPubMed
26.
go back to reference Verma M, Kosinski AS, Volk ML et al. Introducing palliative care within the treatment of end-stage liver disease: The study protocol of a cluster randomized controlled trial. J Palliat Med 2019;22:34–43.CrossRefPubMed Verma M, Kosinski AS, Volk ML et al. Introducing palliative care within the treatment of end-stage liver disease: The study protocol of a cluster randomized controlled trial. J Palliat Med 2019;22:34–43.CrossRefPubMed
Metadata
Title
Increasing Healthcare System Empathy for Patients with Advanced Liver Disease: My Top 10 Lessons in Palliative Hepatology
Author
Nneka N. Ufere
Publication date
04-05-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08406-9

Other articles of this Issue 6/2024

Digestive Diseases and Sciences 6/2024 Go to the issue

Profiles and Perspectives

DDS Profile: Nneka N. Ufere, MD, MSCE

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare